Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05621044 · ClinicalTrials.gov registry record · NA
Physical Activity Smartphone App for African American Men (FitBros) Ph II
A NA study of Health Behavior and Exercise, sponsored by Klein Buendel.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 3
- Study locations
NCT05621044: Completed NA study of Health Behavior and Exercise, sponsored by Klein Buendel.
NCT05621044 is a NA study of Health Behavior and Exercise that has completed, run by Klein Buendel. The registered enrollment target is 36 participants, below the 2,185-participant average among 65 other Health Behavior trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05621044, a NA study of Health Behavior and Exercise, has completed, sponsored by Klein Buendel.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 3
- Study locations
Study Summary
Low physical activity levels contribute to African American men experiencing health disparities across a number of chronic diseases. Studies have been effective in increasing physical activity levels in African American men; but few have targeted maintenance of behavior change and none have utilized emerging technologies. The purpose of the current study is to further develop a mobile phone application for African American men that will help them initiate and maintain their physical activity levels.
Primary Outcome
Steps per day will be collected using the ActiGraph WGT3X+BT accelerometer. The device is worn on the wrist for a 7-day period.
Conditions Studied
Interventions
- BEHAVIORAL FitBrothers smartphone active app
- BEHAVIORAL Nike Training Club
Study Locations (3)
Colorado
- Klein Buendel, Inc. - Golden
District of Columbia
- Georgetown University - Washington D.C.
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2026-01-22 |
| Phase | NA |
What the finished NCT05621044 record still lists
NCT05621044 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 2,185-participant average among 65 other Health Behavior trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Health Behavior appearing as the primary indexed condition, and to 2 interventions - of which FitBrothers smartphone active app is the first listed.
NCT05621044 reports a single indexed study location in Colorado, District of Columbia, Louisiana.
Frequently Asked Questions
What is clinical trial NCT05621044 about?
NCT05621044 is a clinical study titled "Physical Activity Smartphone App for African American Men (FitBros) Ph II". Low physical activity levels contribute to African American men experiencing health disparities across a number of chronic diseases. Studies have been effective in increasing physical activity levels in African American men; but few have targeted maintenance of behavior change and none have utilized...
What is the current status of trial NCT05621044?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2024-05-01. Estimated completion is 2026-01-22.
What conditions does trial NCT05621044 study?
This clinical trial studies the following conditions: Health Behavior, Exercise, Technology.
What interventions are being tested in trial NCT05621044?
The interventions under investigation include: FitBrothers smartphone active app (BEHAVIORAL), Nike Training Club (BEHAVIORAL).
Who is sponsoring clinical trial NCT05621044?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05621044 being conducted?
This trial has 3 study locations across Colorado, District of Columbia, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05621044's enrollment target sits among peer trials
36 57th of 65 higher than 9 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Validation Study of Bioelectronics
RECRUITING · NA
-
A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI